J.P. Morgan Chase increased its holdings of Ali Health (00241) by approximately 27.96 million shares at a price of around HK$5.31 per share.

20:18 24/12/2025

On December 18, J.P. Morgan increased its holdings in Ali Health (00241) by 27.968934 million shares, with a price of 5.3128 Hong Kong dollars per share, totaling approximately 1.49 billion Hong Kong dollars.

According to the latest information from the Hong Kong Stock Exchange, on December 18th, Morgan Stanley increased its stake in ALI HEALTH (00241) by 27.968934 million shares, priced at 5.3128 Hong Kong dollars per share, with a total amount of approximately 149 million Hong Kong dollars. After the increase, the latest number of shares held is approximately 1.321 billion shares, with a latest shareholding ratio of 8.16%.

HK Stock Market Move | XPENG-W (09868) rose more than 6%, the company accelerating its layout in the Middle East and Africa markets, recently reaching a strategic cooperation with a well-known distributor in Mauritius.

HK Stock Market Move | ELIFE HLDGS (00223) resumed trading after more than 1 year and surged 1.61 times in early trading.

Guosen: Maintaining an "outperform" investment rating on LI NING (02331) with a reasonable valuation range of HKD 21.20-22.30.

HK Stock Market Move | ELIFE HLDGS (00223) resumed trading after more than 1 year and surged 1.61 times in early trading.

Guosen: Maintaining an "outperform" investment rating on LI NING (02331) with a reasonable valuation range of HKD 21.20-22.30.